TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TYRA

Tyra Biosciences Inc

Healthcare · Biotechnology

25.70$ +5.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Tyra Biosciences Inc (TYRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 283 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TYRA
Line item 2019 2020 2021 2022 2023 2024 2025
0.5 16 307 266 226 364 283
0.1 15 304 257 212 347 265
0.1 15 302 251 58 92 77
0.1 15 302 251 203 341 256
0.7 2.0
0.3 0.5 1.0 1.1
5.3 30 5.0 8.4 22 20 23
5.2 1.9 3.6 5.7 15 15 18
0.1 0.1 0.2 0.1 0.3 0.4 0.5
0.3 0.7 0.6 1.1 4.7 0.6 1.2
-4.7 -14 302 258 204 343 259
-4.7 -14 -40 -96 -165 -251 -371
43 43 41 42 43 57 60

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?